35.10
price up icon2.12%   0.73
 
loading

Guardant Health Inc Stock (GH) Forecast

The Guardant Health Inc (GH) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $21.67, representing a -38.26% decrease from the current price of $35.10. The highest analyst price target is $27.09, and the lowest is $16.25.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month GH Price Target
Average 36.00 (+2.55% Upside)
loading

Is Guardant Health Inc (GH) A Buy Now?

Oscillators
Name Value Action
RSI(14) 74.83 Sell
STOCH(9,6) 78.23 Neutral
STOCHRSI(14) 64.50 Neutral
MACD(12,26) 2.8503 Buy
ADX(14) 58.55 Buy
William %R -11.76 Sell
CCI(14) 152.91 Buy
Buy: 3 Sell: 2 Neutral: 2
Summary: Buy
Moving Averages
Period Simple Exponential
MA10
31.81
Buy
32.23
Buy
MA20
29.17
Buy
29.81
Buy
MA50
24.81
Buy
27.02
Buy
MA100
26.95
Buy
26.28
Buy
MA200
24.65
Buy
26.52
Buy
Buy: 10 Sell: 0 Neutral: 0
Summary: Buy
According to our latest analysis, GH could be considered a Strong Buy, with 17 technical analysis indicators signaling 13 Buy signals, 2 signaling Sell signals and 2 Neutral signals. This might be a good time to open fresh positions on GH, as trading bullish markets is always a lot easier
  1. RSI (Relative Strength Index): The RSI(14) value of 74.83 indicates that GH is overbought. This suggests that GH price has experienced a significant increase over a specified lookback period, potentially leading to a correction.
  2. STOCH (Stochastic Oscillator): The STOCH value of 78.23 indicates that GH is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 64.5 indicates that GH is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 58.55 suggests an extremely strong trend in the market. Such high values are relatively rare and indicate a very robust directional movement.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 152.91 indicates that GH is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.

Long-term GH price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Guardant Health Inc financial reports and earnings history, Guardant Health Inc (GH) stock could reach $37.79 by 2030, $47.10 by 2040 and $107.53 by 2050. See the projected annual prices until 2050 of the Guardant Health Inc stock below:

  • Guardant Health Inc (GH) is expected to reach an average price of $12.19 in 2035, with a high prediction of $12.16 and a low estimate of $11.96. This indicates an $-65.27% rise from the last recorded price of $35.10.
  • Guardant Health Inc (GH) stock is projected to chart a bullish course in 2040, with an average price target of $47.54, representing an $35.45% surge from its current level. The forecast ranges from a conservative $46.59 to a sky-high $47.10.
  • Our analysts predict Guardant Health Inc (GH) to jump 64.74% by 2045, soaring from $61.03 to an average price of $57.82, potentially reaching $58.10. While $61.03 is the low estimate, the potential upside is significant.
  • Guardant Health Inc (GH) stock is expected to climb by 2050, reaching an average of $107.63, a $206.64% jump from its current level. However, a wide range of estimates exists, with high and low targets of $107.53 and $104.11, respectively, highlighting the market's uncertainty.

Guardant Health Inc Stock (GH) Year by Year Forecast

Guardant Health Inc Stock (GH) Price Forecast for 2024

Our forecast for GH stock price in 2024 now indicates an average price target of $28.12 with a high forecast of $55.11 and a low forecast of $1.1372. The average prediction reflects an decrease of -19.88% from the last recorded price of $35.10.
Month Average Low High Change from today's price
December, 2024 $20.58 $16.25 $27.09 -41.37%

Guardant Health Inc Stock (GH) Price Forecast for 2025

Guardant Health Inc Stock (GH) is expected to reach an average price of $36.67 in 2025, with a high prediction of $68.73 and a low estimate of $4.614. This indicates an +4.48% rise from the last recorded price of $35.10.
Month Average Low High Change from today's price
January, 2025 $25.50 $17.31 $30.71 -27.35%
February, 2025 $23.93 $21.62 $34.20 -31.84%
March, 2025 $31.31 $19.83 $37.79 -10.80%
April, 2025 $17.64 $4.614 $33.33 -49.74%
May, 2025 $23.64 $8.3681 $25.58 -32.65%
June, 2025 $47.79 $21.55 $49.55 +36.15%
July, 2025 $30.09 $25.21 $50.44 -14.27%
August, 2025 $36.87 $28.92 $40.07 +5.04%
September, 2025 $37.88 $29.31 $40.14 +7.92%
October, 2025 $43.84 $31.63 $51.76 +24.90%
November, 2025 $65.42 $41.26 $67.38 +86.38%
December, 2025 $61.06 $53.16 $68.73 +73.96%

Guardant Health Inc Stock (GH) Price Forecast for 2026

The predicted value for Guardant Health Inc (GH) in 2026 is set at an average of $97.64. Estimates vary from a peak of $137.91 to a trough of $57.37, indicating an +178.17% surge from the present price of $35.10.
Month Average Low High Change from today's price
January, 2026 $73.67 $57.37 $77.01 +109.88%
February, 2026 $82.92 $70.37 $85.02 +136.24%
March, 2026 $115.52 $76.02 $119.65 +229.11%
April, 2026 $127.44 $98.68 $137.91 +263.07%
May, 2026 $103.15 $79.07 $128.14 +193.87%
June, 2026 $115.38 $87.22 $122.71 +228.71%
July, 2026 $71.81 $67.00 $128.09 +104.58%
August, 2026 $80.52 $69.45 $87.71 +129.39%
September, 2026 $84.23 $74.46 $91.41 +139.97%
October, 2026 $74.99 $67.53 $86.92 +113.64%
November, 2026 $88.83 $57.91 $88.99 +153.07%
December, 2026 $87.47 $80.37 $95.53 +149.20%

Guardant Health Inc Stock (GH) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Guardant Health Inc (GH) is $42.29, with a high forecast of $84.49 and a low forecast of $0.0853. This indicates an +20.48% increase from the last price of $35.10.
Month Average Low High Change from today's price
January, 2027 $72.36 $61.31 $80.47 +106.15%
February, 2027 $61.12 $60.50 $84.49 +74.12%
March, 2027 $67.40 $49.56 $75.17 +92.02%
April, 2027 $42.49 $39.39 $67.61 +21.05%
May, 2027 $38.52 $24.78 $42.20 +9.73%
June, 2027 $24.20 $22.78 $44.01 -31.06%
July, 2027 $33.13 $13.45 $36.47 -5.62%
August, 2027 $33.42 $31.75 $44.91 -4.80%
September, 2027 $11.26 $0.0853 $38.24 -67.93%
October, 2027 $5.9961 $2.9661 $12.41 -82.92%
November, 2027 $19.87 $6.3084 $21.54 -43.40%
December, 2027 $24.42 $13.26 $27.53 -30.44%

Guardant Health Inc Stock (GH) Price Forecast for 2028

In 2028, Guardant Health Inc (GH) is projected to reach an average price of $17.22, with a high projection of $34.36 and a low estimate of $0.0817. This indicates an -50.94% fall from the last price of $35.10.
Month Average Low High Change from today's price
January, 2028 $23.96 $16.80 $27.24 -31.75%
February, 2028 $25.28 $19.09 $32.82 -27.96%
March, 2028 $21.72 $13.97 $34.36 -38.13%
April, 2028 $24.35 $12.70 $26.99 -30.64%
May, 2028 $1.4865 $1.1842 $27.28 -95.76%
June, 2028 $5.8956 $0.4589 $8.3056 -83.20%
July, 2028 $2.7947 $2.0047 $9.0024 -92.04%
August, 2028 $0.576 $0.224 $8.1188 -98.36%
September, 2028 $0.1949 $0.0817 $5.0933 -99.44%
October, 2028 $0.4342 $0.4497 $1.9597 -98.76%
November, 2028 $9.9356 $0.3135 $10.14 -71.69%
December, 2028 $13.95 $9.2678 $16.37 -60.24%

Guardant Health Inc Stock (GH) Price Forecast for 2029

The 2029 price forecast for Guardant Health Inc Stock (GH) is $19.46 on average, with a high prediction of $37.65 and a low estimate of $1.2737. This represents an -44.55% decrease from the previous price of $35.10.
Month Average Low High Change from today's price
January, 2029 $17.94 $13.06 $18.29 -48.90%
February, 2029 $17.82 $13.88 $18.13 -49.24%
March, 2029 $9.6642 $9.6542 $20.74 -72.47%
April, 2029 $7.7733 $5.6965 $11.10 -77.85%
May, 2029 $3.0846 $2.6946 $10.43 -91.21%
June, 2029 $8.4437 $2.8679 $8.5379 -75.94%
July, 2029 $9.7728 $7.6182 $12.78 -72.16%
August, 2029 $5.4141 $5.2341 $10.64 -84.58%
September, 2029 $3.5132 $3.1982 $7.301 -89.99%
October, 2029 $2.1046 $1.9146 $5.14 -94.00%
November, 2029 $1.5337 $1.2737 $7.7291 -95.63%
December, 2029 $40.43 $2.3859 $37.65 +15.20%

Guardant Health Inc Stock (GH) Price Forecast for 2030

Guardant Health Inc Stock (GH) is expected to reach an average price of $31.74 in 2030, with a high forecast of $45.81 and a low forecast of $17.68. This signifies an -9.56% decrease from the last price of $35.10.
Month Average Low High Change from today's price
January, 2030 $26.85 $30.59 $37.79 -23.50%
February, 2030 $28.22 $29.86 $25.76 -19.60%
March, 2030 $21.19 $22.02 $17.68 -39.63%
April, 2030 $24.96 $17.68 $13.73 -28.88%
May, 2030 $46.48 $31.78 $45.81 +32.41%
June, 2030 $40.95 $44.87 $44.65 +16.67%
July, 2030 $29.87 $31.82 $37.38 -14.90%
August, 2030 $23.49 $31.07 $31.01 -33.07%
September, 2030 $27.01 $27.63 $26.59 -23.04%
October, 2030 $19.67 $26.24 $23.26 -43.96%
November, 2030 $33.69 $22.02 $29.77 -4.01%
December, 2030 $41.90 $35.33 $32.15 +19.38%
diagnostics_research LH
$242.15
price up icon 1.43%
$168.45
price up icon 0.08%
$144.36
price up icon 0.99%
diagnostics_research WAT
$386.57
price down icon 0.41%
diagnostics_research MTD
$1,243.40
price up icon 0.90%
$421.76
price up icon 1.06%
Cap:     |  Volume (24h):